Your browser doesn't support javascript.
loading
High Expression Levels of SIGLEC9 Indicate Poor Outcomes of Glioma and Correlate With Immune Cell Infiltration.
Xu, Heng; Feng, Yanyan; Kong, Weijia; Wang, Hesong; Feng, Yuyin; Zhen, Jianhua; Tian, Lichun; Yuan, Kai.
Afiliación
  • Xu H; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
  • Feng Y; Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, China.
  • Kong W; Beijing Hospital of Traditional Chinese Medicine Clinical Medical College, Beijing University of Chinese Medicine, Beijing, China.
  • Wang H; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
  • Feng Y; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
  • Zhen J; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
  • Tian L; Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
  • Yuan K; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Front Oncol ; 12: 878849, 2022.
Article en En | MEDLINE | ID: mdl-35756603
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China